Perceptive Advisors LLC
- SEC CIK
- 0001224962
- 最新申報
- 2026/8/14
2021 年第 1 季持倉
持倉截至 2021/3/31，2021/8/13 申報。只含多頭部位。
- 持股檔數
- 136
- 2020 年第 4 季沒有 13F 資料
- 總值
- $75.2 億
- 2020 年第 4 季沒有 13F 資料
Livermore 的 13F 資料從 2021 年第 1 季開始，這一季沒有前一季可以比較，所以不顯示股數變化與動作。
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| MORFMorphic Holding, Inc. | COM | 938,140 | $5,937 萬 | 0.8% | – | – | 歷史 |
| QTNTQuotient Ltd | SHS | 16,200,818 | $5,962 萬 | 0.8% | – | – | 歷史 |
| NARIInari Medical, Inc. | Stock | 565,113 | $6,047 萬 | 0.8% | – | – | 歷史 |
| KDMNKadmon Holdings, Inc. | COM | 15,711,334 | $6,112 萬 | 0.8% | – | – | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 987,287 | $6,174 萬 | 0.8% | – | – | 歷史 |
| LONALeonaBio, Inc. | COM | 3,425,916 | $6,304 萬 | 0.8% | – | – | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 4,643,095 | $6,375 萬 | 0.8% | – | – | 歷史 |
| MGNXMacrogenics Inc | COM | 2,148,060 | $6,842 萬 | 0.9% | – | – | 歷史 |
| CHRSCoherus Oncology, Inc. | COM | 4,697,612 | $6,863 萬 | 0.9% | – | – | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 2,018,097 | $6,977 萬 | 0.9% | – | – | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 13,412,552 | $7,417 萬 | 1.0% | – | – | 歷史 |
| KRONKronos Bio, Inc. | COM | 2,780,097 | $7,967 萬 | 1.1% | – | – | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 3,298,419 | $8,236 萬 | 1.1% | – | – | 歷史 |
| ALBOAlbireo Pharma, Inc. | COM | 2,360,139 | $8,320 萬 | 1.1% | – | – | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 941,832 | $9,159 萬 | 1.2% | – | – | 歷史 |
| MGTXMeiraGTx Holdings plc | COM | 6,933,277 | $9,337 萬 | 1.2% | – | – | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 8,703,879 | $1.03 億 | 1.4% | – | – | 歷史 |
| NVRONevro Corp | COM | 812,154 | $1.13 億 | 1.5% | – | – | 歷史 |
| CCCCC4 Therapeutics, Inc. | COM STK | 3,158,566 | $1.17 億 | 1.6% | – | – | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 2,867,771 | $1.27 億 | 1.7% | – | – | 歷史 |
| OMOutset Medical, Inc. | COM | 2,387,535 | $1.30 億 | 1.7% | – | – | 歷史 |
| Nevro Corp64157FAC7 | NOTE 2.750% 4/0 | – | $1.35 億 | 1.8% | – | – | – |
| ZYMEZymeworks Inc. | COM | 4,330,868 | $1.37 億 | 1.8% | – | – | 歷史 |
| LABPLandos Biopharma, Inc. | COM | 14,869,915 | $1.41 億 | 1.9% | – | – | 歷史 |
| VBIVVBI Vaccines Inc/BC | COM NEW | 55,042,465 | $1.71 億 | 2.3% | – | – | 歷史 |
| AVIRAtea Pharmaceuticals, Inc. | COM | 3,109,224 | $1.85 億 | 2.5% | – | – | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 2,050,002 | $1.89 億 | 2.5% | – | – | 歷史 |
| Collegium Pharmaceutical, Inc19459JAA2 | NOTE 2.625% 2/1 | – | $1.90 億 | 2.5% | – | – | – |
| NVTAInvitae Corp | COM | 5,360,673 | $2.05 億 | 2.7% | – | – | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 5,058,642 | $2.06 億 | 2.7% | – | – | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 22,861,329 | $2.26 億 | 3.0% | – | – | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 8,651,785 | $2.74 億 | 3.6% | – | – | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 4,849,912 | $3.57 億 | 4.7% | – | – | 歷史 |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $4.75 億 | 6.3% | – | – | – |
| BBIOBridgeBio Pharma, Inc. | COM | 7,756,928 | $4.78 億 | 6.4% | – | – | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 3,474,505 | $5.95 億 | 7.9% | – | – | 歷史 |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。